Lawrence W Elmer
- Med Dir, Cntr for Neurological Disorders, Neurology , College of Medicine and Life Sciences
Contact Info
Publications
selected publications
-
Article (Web of Science)
-
2021Video Representation of Dopamine-Responsive Multiple System Atrophy Cerebellar Type. AMERICAN JOURNAL OF CASE REPORTS. 22.Full Text via DOI: 10.12659/ajcr.933995
-
2018Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease. CNS DRUGS. 32:387-398.Full Text via DOI: 10.1007/s40263-018-0498-4
-
2017A Randomized Trial of a Low-Dose Rasagiline and Pramipexole Combination (P2B001) in Early Parkinson's Disease. MOVEMENT DISORDERS. 32:783-789.Full Text via DOI: 10.1002/mds.26941
-
2017A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned. PARKINSONISM & RELATED DISORDERS. 37:101-105.Full Text via DOI: 10.1016/j.parkreldis.2017.02.003
-
2017Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea. JAMA NEUROLOGY. 74:977.Full Text via DOI: 10.1001/jamaneurol.2017.1352
-
2015Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical Trials. JOURNAL OF PARKINSONS DISEASE. 5:837-845.Full Text via DOI: 10.3233/JPD-150622
-
2014A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease No Evidence of Benefit. JAMA NEUROLOGY. 71:543-552.Full Text via DOI: 10.1001/jamaneurol.2014.131
-
2014A Randomized Study of Rotigotine Dose Response on 'Off' Time in Advanced Parkinson's Disease. JOURNAL OF PARKINSONS DISEASE. 4:361-373.Full Text via DOI: 10.3233/JPD-130320
-
2013Rasagiline adjunct therapy in patients with Parkinson's disease: Post hoc analyses of the PRESTO and LARGO trials. PARKINSONISM & RELATED DISORDERS. 19:930-936.Full Text via DOI: 10.1016/j.parkreldis.2013.06.001
-
2012Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: A prospective, open-label extension study. PARKINSONISM & RELATED DISORDERS. 18:488-493.Full Text via DOI: 10.1016/j.parkreldis.2012.01.008
-
2012A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. NEUROLOGY. 78:1229-1236.Full Text via DOI: 10.1212/wnl.0b013e3182516244
-
2011Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single-Center Experience. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 34:750-755.Full Text via DOI: 10.1111/j.1540-8159.2011.03047.x
-
2007Ropinirole 24-hour prolonged release - Randomized, controlled study in advanced Parkinson disease. NEUROLOGY. 68:1108-1115.
-
2007Ropinirole 24-hour prolonged release: Randomized, controlled study in advanced Parkinson disease. NEUROLOGY. 68:1108-1115.Full Text via DOI: 10.1212/01.wnl.0000258660.74391.c1
-
2006Aortic Arch Abnormality in a Patient with Klippel-Feil Syndrome. VASCULAR. 14:43-46.Full Text via DOI: 10.2310/6670.2006.00003
-
2006Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms. JOURNAL OF THE NEUROLOGICAL SCIENCES. 248:78-83.Full Text via DOI: 10.1016/j.jns.2006.05.014
-
2005Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease. JOURNAL OF COMMUNICATION DISORDERS. 38:215-230.Full Text via DOI: 10.1016/j.jcomdis.2004.10.001
-
2004Cognitive issues in Parkinson's disease. NEUROLOGIC CLINICS. 22:S91-S106.Full Text via DOI: 10.1016/j.ncl.2004.06.009
-
2004Double-blind, Placebo-Controlled Study of Entacapone in Levodopa-Treated Patients With Stable Parkinson Disease. Archives of Neurology. 61:1563.Full Text via DOI: 10.1001/archneur.61.10.1563
-
2002Cocaine Induction of Dopamine Transporter Trafficking to the Plasma Membrane. MOLECULAR PHARMACOLOGY. 61:436-445.Full Text via DOI: 10.1124/mol.61.2.436
-
2001An open letter to the Committee on The Nobel Prize in Medicine. PARKINSONISM & RELATED DISORDERS. 7:149-155.Full Text via DOI: 10.1016/s1353-8020(00)00082-1
-
1998Expression and regulation of the human dopamine transporter in a neuronal cell line. Molecular Brain Research. 59:66-73.Full Text via DOI: 10.1016/s0169-328x(98)00138-7
-
1997Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. NEUROLOGY. 48:1070-1076.Full Text via DOI: 10.1212/wnl.48.4.1070
-
1993A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. CELL. 72:971-983.Full Text via DOI: 10.1016/0092-8674(93)90585-e
-
1993A simple non-radioactive method for diagnosis of Huntington's disease. HUMAN MOLECULAR GENETICS. 2:633-634.Full Text via DOI: 10.1093/hmg/2.6.633
-
1993Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. NATURE GENETICS. 5:259-265.Full Text via DOI: 10.1038/ng1193-259
-
1989Immuno-ultrastructural localization of sodium channels at nodes of Ranvier and perinodal astrocytes in rat optic nerve. Proceedings of the Royal Society of London. B. Biological Sciences. 238:39-51.Full Text via DOI: 10.1098/rspb.1989.0065
-
1989Sodium channels in astrocytes of rat optic nerve in situ: Immuno-electron microscopic studies. Glia. 2:353-369.Full Text via DOI: 10.1002/glia.440020508
-
1988Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. NATURE. 333:177-180.Full Text via DOI: 10.1038/333177a0
-
1988Distribution and lateral mobility of voltage-dependent sodium channels in neurons [published erratum appears in J Cell Biol 1989 May;108(5):preceding 2001]. JOURNAL OF CELL BIOLOGY. 106:1911-1925.Full Text via DOI: 10.1083/jcb.106.6.1911
-
1985Physicochemical characterization of the .alpha.-peptide of the sodium channel from rat brain. BIOCHEMISTRY. 24:8128-8137.Full Text via DOI: 10.1021/bi00348a044
-
A Randomized Study of Rotigotine Dose Response on ‘Off’ Time in Advanced Parkinson's Disease. Journal of Parkinson's Disease. 4:361-373.Full Text via DOI: 10.3233/jpd-130320
-
Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson’s Disease: Experience in Clinical Trials. Journal of Parkinson's Disease. 5:837-845.Full Text via DOI: 10.3233/jpd-150622
-
Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials. Journal of Parkinson's Disease. 9:591-600.Full Text via DOI: 10.3233/jpd-181565
-
-
Conference Poster (Faculty180)
-
Correction (Web of Science)
-
2018Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease (vol 32, pg 387, 2018). CNS DRUGS. 399-400.Full Text via DOI: 10.1007/s40263-018-0510-z
-
-
Meeting Abstract (Web of Science)
-
201424-hour Efficacy Profile of Rotigotine in Patients with Advanced Parkinson's Disease: A Post-hoc Analysis.. MOVEMENT DISORDERS. E5-E5.
-
2010Identification of Physical, Cognitive, and Affective Variables that Relate to Falls in Parkinson's Disease. MOVEMENT DISORDERS. S642-S642.
-
2009P1.082 A retrospective assessment of physical, cognitive, and affective factors that relate to falls in individuals with Parkinson's disease. PARKINSONISM & RELATED DISORDERS. S50.Full Text via DOI: 10.1016/s1353-8020(09)70204-4
-
2009P2.084 The impact of switching to continuous release dopamine agonists on non-motor side effects. PARKINSONISM & RELATED DISORDERS. S111.Full Text via DOI: 10.1016/s1353-8020(09)70435-3
-
2009P2.160 The effects of a yoga program on Parkinson's disease. PARKINSONISM & RELATED DISORDERS. S133.Full Text via DOI: 10.1016/s1353-8020(09)70511-5
-
2008Adjunctive rasagiline provides significant improvements in all cardinal symptoms in patients with moderate to advanced Parkinson's disease. EUROPEAN JOURNAL OF NEUROLOGY. 108-108.
-
-
Review Article (Web of Science)
-
2017Optimizing extended-release carbidopa/levodopa in Parkinson disease. NEUROLOGY-CLINICAL PRACTICE. 86-93.Full Text via DOI: 10.1212/cpj.0000000000000316
-
2016The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis. CLINICAL NEUROPHARMACOLOGY. 88-93.Full Text via DOI: 10.1097/WNF.0000000000000133
-
2016The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease. CLINICAL NEUROPHARMACOLOGY. 88-93.Full Text via DOI: 10.1097/wnf.0000000000000133
-
2015Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome: post hoc analysis of patients with early Parkinson's disease with mild symptom severity. EXPERT OPINION ON PHARMACOTHERAPY. 1423-1433.Full Text via DOI: 10.1517/14656566.2015.1049597
-
2015Posterior Reversible Encephalopathy Syndrome Secondary to CSF Leak and Intracranial Hypotension: A Case Report and Literature Review. Case Reports in Neurological Medicine. 1-5.Full Text via DOI: 10.1155/2015/538523
-
2011Strategies for Parkinson’s disease care: prevention and management of motor fluctuations. Neurodegenerative Disease Management. 415-430.Full Text via DOI: 10.2217/nmt.11.55
-
2010Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects. CLINICAL NEUROPHARMACOLOGY. 5-10.Full Text via DOI: 10.1097/WNF.0b013e3181b7926f
-
2010Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects. CLINICAL NEUROPHARMACOLOGY. 5-10.Full Text via DOI: 10.1097/wnf.0b013e3181b7926f
-
2009Treatment of Early Parkinson's Disease Part 1. EUROPEAN NEUROLOGY. 193-205.Full Text via DOI: 10.1159/000197103
-
2009Treatment of Early Parkinson's Disease Part 2. EUROPEAN NEUROLOGY. 206-215.Full Text via DOI: 10.1159/000197104
-
2008The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy. EXPERT OPINION ON PHARMACOTHERAPY. 2759-2772.Full Text via DOI: 10.1517/14656560802440455
-
2008The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy. EXPERT OPINION ON PHARMACOTHERAPY. 2759-2772.Full Text via DOI: 10.1517/14656566.9.16.2759
-
Contact
full name
- Lawrence W Elmer
visualizations
Cumulative publications in Scholars@UToledo